Diabetic Foot Ulcer (DFU) Therapy Market - Global Outlook and Forecast 2024-2031

Report ID: 1566879 | Published Date: Jan 2025 | No. of Page: 64 | Base Year: 2024 | Rating: 4 | Webstory: Check our Web story

Diabetic foot ulcer is a major complication of diabetes mellitus, and probably the major component of the diabetic foot.
This report contains market size and forecasts of Diabetic Foot Ulcer (DFU) Therapy in Global, including the following market information:
Global Diabetic Foot Ulcer (DFU) Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Diabetic Foot Ulcer (DFU) Therapy market was valued at 4786.5 million in 2021 and is projected to reach US$ 7376.5 million by 2028, at a CAGR of 6.4% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Wound Care Dressings Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Diabetic Foot Ulcer (DFU) Therapy include ConvaTec, Acelity, Coloplast, 3 M, Smith & Nephew, B. Braun, Medline, Medtronic and Organogenesis, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Diabetic Foot Ulcer (DFU) Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Diabetic Foot Ulcer (DFU) Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Diabetic Foot Ulcer (DFU) Therapy Market Segment Percentages, by Type, 2021 (%)
Wound Care Dressings
Biologics
Therapy Devices
Antibiotic Medications
Others
Global Diabetic Foot Ulcer (DFU) Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Diabetic Foot Ulcer (DFU) Therapy Market Segment Percentages, by Application, 2021 (%)
Neuropathic Ulcers
Ischemic Ulcers
Neuro-ischemic Ulcers
Global Diabetic Foot Ulcer (DFU) Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Diabetic Foot Ulcer (DFU) Therapy Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Diabetic Foot Ulcer (DFU) Therapy revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Diabetic Foot Ulcer (DFU) Therapy revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
ConvaTec
Acelity
Coloplast
3 M
Smith & Nephew
B. Braun
Medline
Medtronic
Organogenesis
Molnlycke Health Care
BSN Medical

Frequently Asked Questions
Diabetic Foot Ulcer Therapy Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Diabetic Foot Ulcer Therapy Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Diabetic Foot Ulcer Therapy Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports